BioSpace News Archive

Biotech Beach

ProciseDx Announces $13 Million Convertible Note Financing and Strong International Growth

ProciseDx Inc. announces a $13 million convertible note financing to support international commercialization of the ProciseDx platform and US regulatory approval.

July 13, 2021
·
3 min read
Business

Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter

Meridian Bioscience, Inc. today provided preliminary revenue results for its third quarter of fiscal 2021.

July 13, 2021
·
7 min read
Business

Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President

Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson’s disease, announced that Ana Sousa has joined the company as senior vice president of regulatory affairs and quality, and as a member of the company’s executive team.

July 13, 2021
·
2 min read
Genetown

Genetics Institute of America Selects Ovation LIMS to Accelerate Advanced Molecular Testing

Genetics Institute of America, a CLIA Certified/CAP Accredited DNA and RNA research and clinical laboratory, today announced that it has selected Ovation’s laboratory information management system (LIMS) to complement the growth of its advanced molecular testing business

July 13, 2021
·
3 min read
Business

AbCellera Appoints Neil Berkley as Chief Business Officer

AbCellera announced today that Neil Berkley has been appointed as Chief Business Officer (CBO).

July 13, 2021
·
4 min read
Business

Personal Genome Diagnostics Appoints Mark Sausen as Vice President, Technology Innovation

Personal Genome Diagnostics Inc. today announced the appointment of Mark Sausen, Ph.D., as Vice President, Technology Innovation.

July 13, 2021
·
3 min read
FDA

FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study, AVM0703-001, entitled “The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma”

July 13, 2021
·
5 min read
FDA

FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study, AVM0703-001, entitled “The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma”.

July 13, 2021
·
5 min read
Pharm Country

Phosphorus Launches GeneCompass™: The First Comprehensive, Affordable, Medical-Grade Preventative Genetic Test for Consumers

Phosphorus, a leading preventative genomics company, today announced the immediate availability of GeneCompass, the first holistic consumer genetic test built with medical-grade technology.

July 13, 2021
·
3 min read
Biotech Beach

Groundbreaking Study Establishes Non-Surgical Treatment Modality to Improve Function in Children With Cerebral PalsySpineX’s Proprietary SCONE™ Device Offers New Hope to Families of Children with CP

SpineX, Inc., today announced the publication of new data in the esteemed medical journal, Neurotherapeutics which supports the implementation of their SCONE™ device providing non-surgical treatment for children with Cerebral Palsy (CP).

July 13, 2021
·
2 min read